FCF Fox Company Finance GmbH is delighted to publish the brand new “FCF Life Sciences Enterprise Capital Monitor – Europe 01/2022”.
The Monitor is a month-to-month printed overview of enterprise capital developments within the European Life Sciences sector.
As of the tip of January 2022 we determine the next present VC developments in Europe:
- The present funding for all times sciences quantities to EUR 957m and is thus about EUR 400m under the earlier 12 months’s degree
- The highest 5 offers are every above EUR 50m, the biggest deal is above EUR 100m and happened in Germany (Affected person21)
- Goal International (Germany) ranks first among the many prime 5 traders (by deal quantity), adopted by Piton Capital (UK) and Eight Roads (USA)
- 35% of complete funding quantity was positioned within the biotech sector (+7% factors month-on-month)
- Infectious illnesses is the indication with the best funding exercise within the biotech sector
To entry the complete report, please click on right here.
By Dr. Mathias Schott and Sebastian Sommer